GlaxoSmithKline is seeking a development partner to transform its 92-acre R&D site in Stevenage into the UK's second-largest life sciences cluster. The British pharmaceuticals group has appointed Cushman & Wakefield to find a partner later this year. GSK believes that
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.